Kubbutat M H, Ludwig R L, Levine A J, Vousden K H
ABL Basic Research Program, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702-1201, USA.
Cell Growth Differ. 1999 Feb;10(2):87-92.
Degradation of the p53 tumor suppressor protein has been shown to be regulated by Mdm2. In this study, we identify regions of Mdm2 that are not required for p53 binding but are essential for degradation. Mdm2 mutants lacking these regions function in a dominant negative fashion, stabilizing endogenous p53 in cells by interfering with the degradative function of the endogenous Mdm2. p53 protein stabilized in this way does not strongly enhance the expression of p21(Waf1/Cip1), the product of a p53-responsive gene, supporting the model in which binding of Mdm2 to the NH2-terminal domain of p53 inhibits interaction with other components of the basal transcriptional machinery. Interestingly, COOH-terminal truncations of Mdm2 that retain p53 binding but fail to mediate its degradation are also stabilized themselves. Because Mdm2, like p53, is normally an unstable protein that is degraded through the proteasome, this result suggests a direct link between the regulation of Mdm2 and p53 stability.
p53肿瘤抑制蛋白的降解已被证明受Mdm2调控。在本研究中,我们确定了Mdm2中对p53结合并非必需但对降解至关重要的区域。缺乏这些区域的Mdm2突变体以显性负性方式发挥作用,通过干扰内源性Mdm2的降解功能来稳定细胞中的内源性p53。以这种方式稳定的p53蛋白不会强烈增强p53反应基因产物p21(Waf1/Cip1)的表达,这支持了Mdm2与p53氨基末端结构域结合会抑制其与基础转录机制其他成分相互作用的模型。有趣的是,保留p53结合但无法介导其降解的Mdm2羧基末端截短体自身也会被稳定。由于Mdm2与p53一样,通常是一种通过蛋白酶体降解的不稳定蛋白,这一结果表明Mdm2调控与p53稳定性之间存在直接联系。